| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.06 |